Omega Therapeutics Spikes On R&D Partnership With Novo Nordisk
Omega Therapeutics, Inc. (OMGA) shares are gaining more than 89 percent on Thursday morning trade after Novo Nordisk (NVO) announced a research and development partnership with Omega and Cellarity.